BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 29214653)

  • 1. Administrative billing codes accurately identified occurrence of electrical cardioversion and ablation/maze procedures in a prospective cohort study of atrial fibrillation patients.
    Ehlert AN; Heckbert SR; Wiggins KL; Thacker EL
    Clin Cardiol; 2017 Dec; 40(12):1227-1230. PubMed ID: 29214653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validating emergency department cardioversion procedures in provincial administrative data in Ontario, Canada.
    Atzema CL; Stiell IG; Chong AS; Austin PC
    PLoS One; 2022; 17(12):e0277598. PubMed ID: 36454739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes after cardioversion and atrial fibrillation ablation in patients treated with rivaroxaban and warfarin in the ROCKET AF trial.
    Piccini JP; Stevens SR; Lokhnygina Y; Patel MR; Halperin JL; Singer DE; Hankey GJ; Hacke W; Becker RC; Nessel CC; Mahaffey KW; Fox KA; Califf RM; Breithardt G;
    J Am Coll Cardiol; 2013 May; 61(19):1998-2006. PubMed ID: 23500298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes in patients requiring cardioversion following catheter ablation of atrial fibrillation.
    Chilukuri K; Dukes J; Dalal D; Marine JE; Henrikson CA; Scherr D; Sinha S; Berger R; Cheng A; Nazarian S; Spragg D; Calkins H
    J Cardiovasc Electrophysiol; 2010 Jan; 21(1):27-32. PubMed ID: 19793148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of practice patterns in the treatment of atrial fibrillation among the commercially insured.
    Liu J; Sylwestrzak G; Barron J; Rosenberg A; White J; Whitney J; Redberg R; Malenka D
    Curr Med Res Opin; 2014 Sep; 30(9):1707-13. PubMed ID: 24809834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of stroke after catheter ablation versus cardioversion for atrial fibrillation: A propensity-matched study of 24,244 patients.
    Noseworthy PA; Kapa S; Deshmukh AJ; Madhavan M; Van Houten H; Haas LR; Mulpuru SK; McLeod CJ; Asirvatham SJ; Friedman PA; Shah ND; Packer DL
    Heart Rhythm; 2015 Jun; 12(6):1154-61. PubMed ID: 25708883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contemporary Management of Direct Oral Anticoagulants During Cardioversion and Ablation for Nonvalvular Atrial Fibrillation.
    Trujillo TC; Dobesh PP; Crossley GH; Finks SW
    Pharmacotherapy; 2019 Jan; 39(1):94-108. PubMed ID: 30548542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maintenance of sinus rhythm after electrical cardioversion for recurrent atrial fibrillation following mitral valve surgery with or without associated radiofrequency ablation.
    van Breugel HN; Gelsomino S; de Vos CB; Accord RE; Tieleman RG; Lucà F; Rostagno C; Renzulli A; Parise O; Lorusso R; Crijns HJ; Maessen JG
    Int J Cardiol; 2014 Aug; 175(2):290-6. PubMed ID: 24882697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes after catheter ablation and cardioversion in patients with non-valvular atrial fibrillation: results from the prospective, observational XANTUS study.
    Camm AJ; Turpie AGG; Hess S; Amarenco P; Lambelet M; Haas S; van Eickels M; Kirchhof P;
    Europace; 2018 Jun; 20(6):e87-e95. PubMed ID: 29016755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic analysis of a transesophageal echocardiography-guided approach to cardioversion of patients with atrial fibrillation: the ACUTE economic data at eight weeks.
    Klein AL; Murray RD; Becker ER; Culler SD; Weintraub WS; Jasper SE; Lieber EA; Apperson-Hansen C; Heerey AM; Grimm RA;
    J Am Coll Cardiol; 2004 Apr; 43(7):1217-24. PubMed ID: 15063433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrial defibrillation threshold as a novel predictor of clinical outcome of catheter ablation for persistent atrial fibrillation.
    Komatsu Y; Uno K; Otomo K; Nagata Y; Taniguchi H; Ogura K; Egami Y; Takayama K; Kakita K; Iesaka Y
    Europace; 2011 Feb; 13(2):213-20. PubMed ID: 20884638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Impact of First Procedure Success Rate on the Economics of Atrial Fibrillation Ablation.
    Mansour M; Karst E; Heist EK; Dalal N; Wasfy JH; Packer DL; Calkins H; Ruskin JN; Mahapatra S
    JACC Clin Electrophysiol; 2017 Feb; 3(2):129-138. PubMed ID: 29759385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of Algorithms to Identify Invasive Electrophysiology Procedures Using Administrative Data in Ontario, Canada.
    Singh SM; Webster L; Calzavara A; Wijeysundera HC
    Med Care; 2017 Jun; 55(6):e44-e50. PubMed ID: 25415560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonpharmacologic strategies for treating atrial fibrillation.
    Lüderitz B; Pfeiffer D; Tebbenjohanns J; Jung W
    Am J Cardiol; 1996 Jan; 77(3):45A-52A. PubMed ID: 8607391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimal energy requirement for external cardioversion and catheter ablation for long-standing persistent atrial fibrillation.
    Kim IS; Kim TH; Yang PS; Uhm JS; Joung B; Lee MH; Pak HN
    J Cardiol; 2017 Jan; 69(1):162-168. PubMed ID: 26987790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study on the Effect of Irbesartan on Atrial Fibrillation Recurrence in Kumamoto: Atrial Fibrillation Suppression Trial (SILK study).
    Yamabe H; Kaikita K; Matsumura T; Iwasa A; Koyama J; Uemura T; Morikami Y; Tsunoda R; Morihisa K; Fujimoto K; Kajiwara I; Matsui K; Tsujita K; Ogawa H
    J Cardiol; 2018 Feb; 71(2):129-134. PubMed ID: 28886992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cardioversion efficacy of nifekalan in patients with sustained atrial fibrillation after radiofrequency ablation].
    Li F; Xia Z; Yu JH; Chen Q; Hu JZ; Zhu B; Xia ZR; Huang QH; Li JX; Hong K; Wu YQ; Cheng XS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Dec; 47(12):963-968. PubMed ID: 31877591
    [No Abstract]   [Full Text] [Related]  

  • 18. Left atrial longitudinal strain by speckle tracking as independent predictor of recurrence after electrical cardioversion in persistent and long standing persistent non-valvular atrial fibrillation.
    Moreno-Ruiz LA; Madrid-Miller A; Martínez-Flores JE; González-Hermosillo JA; Arenas-Fonseca J; Zamorano-Velázquez N; Mendoza-Pérez B
    Int J Cardiovasc Imaging; 2019 Sep; 35(9):1587-1596. PubMed ID: 30993507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of cardioversion on asymptomatic cerebral lesions following atrial fibrillation ablation.
    Liu G; Chen R; Zhu W; Cheng K; Xu Y; Chen Q; Ge J
    J Interv Card Electrophysiol; 2014 Aug; 40(2):129-36. PubMed ID: 24928483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of biatrial defragmentation in patients with paroxysmal atrial fibrillation: results from a randomized prospective study.
    Nührich JM; Steven D; Berner I; Rostock T; Hoffmann B; Servatius H; Sultan A; Lüker J; Treszl A; Wegscheider K; Willems S
    Heart Rhythm; 2014 Sep; 11(9):1536-42. PubMed ID: 24907643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.